Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel A Hamstra

Showing results (31-40 of 130) with videos related to

Pageof 13
Sort By:
American Journal of Clinical Oncology|September 26, 2013
Time to Nadir PSA: Of Popes and PSA--The Immortality BiasSkyler B Johnson, William C Jackson, Jure Murgic, et al.
Translational Oncology|July 9, 2008
Gemcitabine-mediated radiosensitization of human soft tissue sarcomaJames D Murphy, David R Lucas, Yash R Somnay, et al.
Radiation Oncology (London, England)|August 3, 2012
The role of the maximum involvement of biopsy core in predicting outcome for patients treated with dose-escalated radiation therapy for prostate cancerJure Murgic, Matthew H Stenmark, Schuyler Halverson, et al.
Frontiers in Oncology|August 29, 2025
Rectal spacer use and overall long-term healthcare costs: payer perspectiveJames B Yu, Ryoko Sato, Michael R Folkert, et al.
International Journal of Radiation Oncology, Biology, Physics|February 25, 2011
The percent of positive biopsy cores improves prediction of prostate cancer-specific death in patients treated with dose-escalated radiotherapyYushen Qian, Felix Y Feng, Schuyler Halverson, et al.
Practical Radiation Oncology|July 24, 2018
Spinal Growth Patterns After Craniospinal Irradiation in Children With MedulloblastomaSkyler B Johnson, Jonathon Hung, Nirav Kapadia, et al.
International Journal of Radiation Oncology, Biology, Physics|June 8, 2011
Continued benefit to androgen deprivation therapy for prostate cancer patients treated with dose-escalated radiation therapy across multiple definitions of high-risk diseaseMatthew H Stenmark, Kevin Blas, Schuyler Halverson, et al.
International Journal of Radiation Oncology, Biology, Physics|November 8, 2011
Percentage of cancer volume in biopsy cores is prognostic for prostate cancer death and overall survival in patients treated with dose-escalated external beam radiotherapySean M Vance, Matthew H Stenmark, Kevin Blas, et al.
Cancer Medicine|December 13, 2025
Association Between Rectal Spacer Use and Erectile Dysfunction Diagnosis Among Men Receiving Prostate Radiotherapy: US County-Level AnalysisRyan Hankins, Sean P Collins, Ryoko Sato, et al.
Practical Radiation Oncology|December 12, 2025
To Space or Not to Space: The EPIC Question for Prostate Stereotactic Radiotherapy (SBRT) with or without Hydrogel Rectal Spacer (RS)Madeline M Flanagan, Mhd Hasan Almekdash, Sean P Collins, et al.
Pageof 13

Showing results (31-40 of 130) with videos related to

Sort By:
Pageof 13
American Journal of Clinical Oncology|September 26, 2013
Time to Nadir PSA: Of Popes and PSA--The Immortality BiasSkyler B Johnson, William C Jackson, Jure Murgic, et al.
Translational Oncology|July 9, 2008
Gemcitabine-mediated radiosensitization of human soft tissue sarcomaJames D Murphy, David R Lucas, Yash R Somnay, et al.
Radiation Oncology (London, England)|August 3, 2012
The role of the maximum involvement of biopsy core in predicting outcome for patients treated with dose-escalated radiation therapy for prostate cancerJure Murgic, Matthew H Stenmark, Schuyler Halverson, et al.
Frontiers in Oncology|August 29, 2025
Rectal spacer use and overall long-term healthcare costs: payer perspectiveJames B Yu, Ryoko Sato, Michael R Folkert, et al.
International Journal of Radiation Oncology, Biology, Physics|February 25, 2011
The percent of positive biopsy cores improves prediction of prostate cancer-specific death in patients treated with dose-escalated radiotherapyYushen Qian, Felix Y Feng, Schuyler Halverson, et al.
Practical Radiation Oncology|July 24, 2018
Spinal Growth Patterns After Craniospinal Irradiation in Children With MedulloblastomaSkyler B Johnson, Jonathon Hung, Nirav Kapadia, et al.
International Journal of Radiation Oncology, Biology, Physics|June 8, 2011
Continued benefit to androgen deprivation therapy for prostate cancer patients treated with dose-escalated radiation therapy across multiple definitions of high-risk diseaseMatthew H Stenmark, Kevin Blas, Schuyler Halverson, et al.
International Journal of Radiation Oncology, Biology, Physics|November 8, 2011
Percentage of cancer volume in biopsy cores is prognostic for prostate cancer death and overall survival in patients treated with dose-escalated external beam radiotherapySean M Vance, Matthew H Stenmark, Kevin Blas, et al.
Cancer Medicine|December 13, 2025
Association Between Rectal Spacer Use and Erectile Dysfunction Diagnosis Among Men Receiving Prostate Radiotherapy: US County-Level AnalysisRyan Hankins, Sean P Collins, Ryoko Sato, et al.
Practical Radiation Oncology|December 12, 2025
To Space or Not to Space: The EPIC Question for Prostate Stereotactic Radiotherapy (SBRT) with or without Hydrogel Rectal Spacer (RS)Madeline M Flanagan, Mhd Hasan Almekdash, Sean P Collins, et al.
Pageof 13